Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Iscience|November 25, 2021
Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cellsGalina Gabriely, Duanduan Ma, Shafiuddin Siddiqui, et al.Nature Communications|August 14, 2021
PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasisThais G Moreira, Davide Mangani, Laura M Cox, et al.Brain, Behavior, and Immunity|January 28, 2024
Gamma-delta T cells suppress microbial metabolites that activate striatal neurons and induce repetitive/compulsive behavior in miceLaura M Cox, Bruna K Tatematsu, Lydia Guo, et al.Frontiers in Immunology|September 3, 2021
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot StudyThais G Moreira, Kimble T F Matos, Giovana S De Paula, et al.Frontiers in Immunology|December 12, 2022
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjectsTanuja Chitnis, Belinda J Kaskow, Junning Case, et al.Frontiers in Immunology|January 31, 2022
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot StudyThais G Moreira, Kimble T F Matos, Giovana S De Paula, et al.Mucosal Immunology|June 26, 2024
Dietary protein modulates intestinal dendritic cells to establish mucosal homeostasisThais G Moreira, Laura M Cox, Patrick Da Silva, et al.Nature Neuroscience|February 27, 2025
Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent Treg-microglia crosstalkSaef Izzy, Taha Yahya, Omar Albastaki, et al.Pageof 2